Investigation of changes in blood antibody titer caused by COVID-1.9 vaccination in patients with hematological disorders

Investigation of changes in blood antibody titer caused by COVID-1.9 vaccination in patients with hematological disorders - Study of Antibody Titer of COVID-19 Vaccine in Hematological Disorders

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045150

Enrollment

380

Registered

2021-09-15

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Disorders

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hematological disorders and healthy volunteers with consent.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The rate of antibody acquisition for each hematological disorders.	—

Countries

Japan

Contacts

Public ContactAkinao Okamoto

Fujita Health University School of Medicine Department of Hematology

aokamoto@fujita-hu.ac.jp0562-93-9243

Outcome results